This Is MS Multiple Sclerosis Knowledge & Support Community

Dalfampridine (Ampyra) extended-release tablets have been approved by the U.S. Food and Drug Administration to help adults with multiple sclerosis (MS) who have trouble walking. In clinical testing, people who took Ampyra had faster walking speeds that those who took a placebo, the agency said in a ...